Tamoxifen and contralateral breast cancer: the other side.
Swain
S M
SM
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008024:Ligands; D008875:Middle Aged; D015233:Models, Statistical; D010919:Placebos; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D011960:Receptors, Estrogen / Q000096:biosynthesis; D012189:Retrospective Studies; D012306:Risk; D013629:Tamoxifen / Q000627:therapeutic use*; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D008024:Ligands; D010919:Placebos; D011960:Receptors, Estrogen; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride